Nonprofit · EIN 76-0566689
CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION
Tax-exempt · HOUSTON, TX 77098
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990-EZ | $11,443 | $100,750 | -$89,307 | $50,660 | $0 | $50,660 |
| December 31, 2024 | 990-EZ | $24,001 | $750 | $23,251 | $139,967 | $0 | $139,967 |
| December 31, 2023 | 990-EZ | $33,496 | $750 | $32,746 | $116,716 | $0 | $116,716 |
Financial details: 990-EZ for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $11,323
- Program service revenue
- $0
- Investment income
- $120
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $100,000
- Compensation of officers, directors and key employees
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fees and payments to contractors
- $750
- Program services (functional)
- $100,000
Balance sheet and other
- Total assets, start of year
- $139,967
- Total assets, end of year
- $50,660
- Total liabilities, end of year
- $0
- Net assets, end of year
- $50,660
- Cash, savings and investments
- $50,660
- Gross receipts
- $11,443
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| HAYDEN BURNS | DIRECTOR | 10 | $0 |
990-EZ for the year ended December 31, 2024: 1 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| HAYDEN BURNS | DIRECTOR | 10 | $0 |
990-EZ for the year ended December 31, 2023: 1 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| HAYDEN BURNS | DIRECTOR | 10 | $0 |
Address and contacts
- Address (IRS master file)
- 1721 NORTH BLVD, HOUSTON, TX 77098-5413
- In care of
- % ROBERT H BURNS
- Signed the 990-EZ
- HAYDEN BURNS, DIRECTOR
- Phone
- (713) 542-1183
- Website
- www.cllfoundation.org
Mission
LEUKEMIA RESEARCH AND EDUCATION
Program accomplishments
- LEUKMIA RESEARCH AND EDUCATIONExpenses $100,000
What it must file and when
IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990-EZ on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990-EZ on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990-EZ on file |
IRS record
- EIN
- 76-0566689
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1998
- Accounting year ends
- December
- Files
- Form 990-N (e-Postcard)
- Category (NTEE)
- Medical research (H20)
- Assets (IRS master file)
- $50,660
- Income (IRS master file)
- $11,443
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990-EZ | December 2025 | $11,443 | $100,750 | $50,660 | IRS |
| 990-EZ | December 2024 | $24,001 | $750 | $139,967 | IRS |
| 990-EZ | December 2023 | $33,496 | $750 | $116,716 | XML |
| 990-EZ | December 2022 | – | – | – | IRS |
| 990-EZ | December 2021 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 76-0566689).
Questions about CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION
- What is the EIN of CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION?
- The employer identification number (EIN) of CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION is 76-0566689.
- Is CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1998.
- Are donations to CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION file?
- Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
- When is the next return of CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
- Who are the officers and directors of CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION?
- The 990-EZ for the year ended December 31, 2025 lists 1 person; 0 received compensation from the organization.
- How much revenue does CHRONIC LYMPHOCYTIC LEUKEMIA FOUNDATION have?
- On its 990-EZ for the year ended December 31, 2025 it reported revenue of $11,443, expenses of $100,750 and total assets of $50,660 at year end.
Other nonprofits in HOUSTON
- LEDUCQ FOUNDATION FOR CARDIOVASCULAR RESEARCH EIN 45-4696263 · last filed 990-PF for 2024
- TEXAS HEART INSTITUTE EIN 74-6053200 · last filed 990 for 2024
- HOUSTON REGIONAL HIV AIDS RESOURCE GROUP INC EIN 76-0414232 · last filed 990 for 2021
- CLAYTON FOUNDATION FOR RESEARCH EIN 74-1541767 · last filed 990 for 2024
- MYASTHENIA GRAVIS FOUNDATION OF AMERICA INC EIN 13-5672224 · last filed 990 for 2025
- RETINA RESEARCH FOUNDATION PERMANENT ENDOWMENT FUND EIN 74-1860430 · last filed 990 for 2024
- SIUT NORTH AMERICA INC EIN 76-0656947 · last filed 990 for 2024
- CLL GLOBAL RESEARCH FOUNDATION EIN 88-0517430 · last filed 990 for 2025